Dossier · Defunct or wound down · 4 independent sources
BioFishency
Last updated: Jul 31, 2026
BioFishency was an Israeli aquaculture-water-treatment startup that developed compact biological and electro-chemical systems for land-based and recirculating aquaculture. Public ecosystem data now marks the company non-active and reports that it ceased operating in January 2026, so this record is primarily a historical technology and strategic-relevance assessment.
Visit WebsiteCompany Overview
BioFishency developed water-treatment equipment for fish and shrimp farms, with a focus on land-based aquaculture and recirculating aquaculture systems (RAS). Its product descriptions centered on modular, plug-and-play treatment rather than on building an entire farm from scratch. The reported product family included the SPB biological filter and the ELX electro-chemical water-treatment platform. Public descriptions associate the systems with biological filtration, solids handling, ammonia and nitrite management, carbon-dioxide removal, oxygenation, disinfection, and tighter control of water exchange. The company also promoted electro-chemical treatment for removing off-flavor compounds such as geosmin and MIB, which can reduce the marketability of otherwise healthy farmed fish. These are meaningful operational problems: water chemistry directly affects fish survival, growth, stocking density, labor, discharge, and harvest quality.
The commercial customer is an aquaculture operator or integrator that needs more predictable production from constrained land and water resources. RAS can reduce water consumption and permit production close to markets, but it is equipment-intensive, energy-sensitive, and operationally unforgiving. BioFishency’s historical positioning was to lower the complexity or cost barrier for farms that could not justify a large bespoke RAS installation, while also helping existing ponds or tanks improve productivity. Public sources describe deployed or demonstrated systems in several geographies and species contexts, including fish, shrimp, and cold-water applications, but the available evidence does not establish a durable installed base, recurring service revenue, or current customer concentration. The strongest historical traction signals are a reported 2018 sales figure in Globes, a 2019 financing round, product demonstrations with research institutions, and later Israeli pilot-facility activity; each should be treated as a point-in-time signal rather than proof of present commercial scale.
Competition comes from specialist RAS designers, aquaculture filtration and oxygenation vendors, disinfection providers, and larger water-treatment companies that can bundle equipment, engineering, and service. BioFishency’s proposed differentiation was the integration of biological and electro-chemical treatment in a compact system, with off-flavor remediation as an additional product-quality argument. That bundle could reduce the number of separate subsystems a farm must procure, but it also creates validation and support burdens: operators need reliable performance across species, salinity, temperature, feed loads, and farm designs. The public record is not sufficient to compare lifecycle cost, energy consumption, uptime, maintenance intervals, intellectual-property defensibility, or field results against alternatives. Those gaps matter more than a broad claim of technical novelty because aquaculture infrastructure purchases are capital-sensitive and failures can cause immediate biological and financial losses.
For Claw & Talon, BioFishency is best understood as a historical resilience and water-efficiency case, not as a defense technology company. Reliable aquaculture can support food production in water-constrained or import-dependent regions, and compact treatment equipment may be useful in remote or controlled environments. That is a strategic adjacency, not substantive defense applicability: there is no reliable public evidence here of military customers, security missions, contested-logistics deployments, or defense procurement. The company’s January 2026 non-active status is the dominant current diligence fact. Any assessment of technology transfer, remaining intellectual property, installed equipment, liabilities, successor activity, or acquisition opportunities would require direct registry, creditor, asset, and management verification that is outside the public evidence captured in this record. Historical relevance remains useful for mapping Israeli water and food-resilience capabilities, but the company should not be treated as an active startup or current strategically relevant priority.
Strategic Fit Assessment
The historical technology addressed a real aquaculture bottleneck and attracted reported financing from The Trendlines Group and Aqua-Spark, but current public ecosystem data marks BioFishency non-active and reports that it ceased operating in January 2026. It is therefore not an active priority signal. Any residual strategic interest would require diligence on surviving intellectual property, installed systems, customer obligations, assets, and a legally valid successor or acquisition path.
Strategic Value to U.S.-Israel Alliance
Historical value as an Israeli example of water-efficient food-production infrastructure and aquaculture process engineering. The company has limited direct defense relevance, and its reported wind-down means current strategic value depends on whether technology, personnel, equipment, or intellectual property remain recoverable.
Key Technologies
- Recirculating aquaculture system water treatment
- Electro-chemical water treatment and disinfection
- Biological filtration for ammonia and nitrite control
- Mechanical solids filtration and water-quality conditioning
- Carbon-dioxide removal and oxygenation
- Geosmin and MIB off-flavor remediation
- Modular aquaculture process-control systems
Use Cases & Applications
- Land-based fish farming
- Recirculating fish-farm water treatment
- Warm-water shrimp production
- Cold-water aquaculture applications
- Ammonia and nitrite management in ponds and tanks
- Off-flavor reduction before fish harvest
- Water-saving production in resource-constrained locations
- Research and pilot aquaculture facilities
Sources and verification
This profile is based on public-source research, Claw & Talon curation, and editorial judgment. Inclusion does not imply endorsement, partnership, investment, or a recommendation to transact. Readers should still confirm current status, customers, funding, and product claims before relying on this profile. The editorial policy explains how profiles are researched, where automated drafting is used, and how corrections work; the research methodology documents how evidence is graded, what counts as an independent source, and why some profiles are excluded from search indexing.
This record lists 6 public references used for company identity, status, positioning, or material-claim review.
Public sources
The links below are visible public references used for source discipline around company identity, status, funding, customer, acquisition, public-company, or other material claims where available.
- BioFishency official website Official company domain referenced by the company and Israeli water-industry directories; the local check reported a hostname/certificate mismatch, so current site availability and content require separate verification.
- Biofishency Ltd. | LinkedIn Company profile describing electro-chemical and biological RAS treatment, founded in 2013, Atlit headquarters, private ownership, and a historical 11-50 employee range.
- BioFishency | Startup Nation Finder Ecosystem profile describing the products, historical financing, founders, employee estimates, and a current page status of Non Active with cessation of operations reported in January 2026.
- Israeli aquaculture co BioFishency raises $2.4m Reputable historical reporting on the 2019 financing and reported commercial context; it does not establish current operations.
- BioFishency Hails First-in-the-World Success in Electro-Chemical Removal of Off-Flavors Company-distributed release describing ELX, Technion-related testing, and off-flavor-removal claims; claims are presented as company-reported technical validation.
- Israeli Water Directory 2025 Industry directory listing BioFishency’s domain and describing compact biological and mechanical aquaculture water-treatment functions; directory inclusion is not proof of current operations.
- Profile update timestamp Last updated in the Claw & Talon database on Jul 31, 2026.
Related sector
See the Industrial, Energy & Climate sector page for market context, related subcategories, and other Israeli companies in this part of the database.